Table 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Breakdown of case and control classification in the test data (N = 25,369) using 10-year risks from the Gail model with and without PRSBC, with a fixed proportion (2.88%) of women considered at “moderate risk”.